• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

规范转基因食品。美国、加拿大和欧盟的政策轨迹、政治文化与风险认知

Regulating genetically modified food. Policy trajectories, political culture, and risk perceptions in the U.S., Canada, and EU.

作者信息

Wohlers Anton E

机构信息

Department of History and Government, South Shepler Center 630, Cameron University, Lawton, OK 73505, USA.

出版信息

Politics Life Sci. 2010 Sep;29(2):17-39. doi: 10.2990/29_2_17.

DOI:10.2990/29_2_17
PMID:21761979
Abstract

This paper examines whether national differences in political culture add an explanatory dimension to the formulation of policy in the area of biotechnology, especially with respect to genetically modified food. The analysis links the formulation of protective regulatory policies governing genetically modified food to both country and region-specific differences in uncertainty tolerance levels and risk perceptions in the United States, Canada, and European Union. Based on polling data and document analysis, the findings illustrate that these differences matter. Following a mostly opportunistic risk perception within an environment of high tolerance for uncertainty, policymakers in the United States and Canada modified existing regulatory frameworks that govern genetically modified food in their respective countries. In contrast, the mostly cautious perception of new food technologies and low tolerance for uncertainty among European Union member states has contributed to the creation of elaborate and stringent regulatory policies governing genetically modified food.

摘要

本文探讨政治文化方面的国家差异是否为生物技术领域的政策制定增添了解释维度,尤其是在转基因食品方面。该分析将有关转基因食品的保护性监管政策的制定与美国、加拿大和欧盟在不确定性容忍度和风险认知方面的国家及地区差异联系起来。基于民意调查数据和文件分析,研究结果表明这些差异很重要。在美国和加拿大,政策制定者在对不确定性高度容忍的环境中大多持机会主义的风险认知,从而修改了各自国家管理转基因食品的现有监管框架。相比之下,欧盟成员国对新食品技术大多持谨慎态度且对不确定性容忍度较低,这促成了管理转基因食品的详尽且严格的监管政策的制定。

相似文献

1
Regulating genetically modified food. Policy trajectories, political culture, and risk perceptions in the U.S., Canada, and EU.规范转基因食品。美国、加拿大和欧盟的政策轨迹、政治文化与风险认知
Politics Life Sci. 2010 Sep;29(2):17-39. doi: 10.2990/29_2_17.
2
Rethinking US leadership in food biotechnology.重新审视美国在食品生物技术领域的领导地位。
Nat Biotechnol. 2003 Aug;21(8):852-4. doi: 10.1038/nbt0803-852.
3
The science and politics of plant biotechnology--a personal perspective.植物生物技术的科学与政治——个人观点
Nat Biotechnol. 2003 Aug;21(8):849-51. doi: 10.1038/nbt0803-849.
4
The ethics of biotechnology.生物技术的伦理道德
J Biolaw Bus. 2000;Suppl.:111-5.
5
Creating public alienation: expert cultures of risk and ethics on GMOs.制造公众疏离感:转基因生物风险与伦理的专家文化
Sci Cult (Lond). 2001 Dec;10(4):445-81. doi: 10.1080/09505430120093586.
6
EU reflects European public opinion.欧盟反映欧洲公众舆论。
Nat Biotechnol. 2003 Sep;21(9):976. doi: 10.1038/nbt0903-976a.
7
Labeling of genetically modified food: closer to reality in the United States?转基因食品的标签:在美国更接近现实了吗?
Politics Life Sci. 2013 Spring;32(1):73-84. doi: 10.2990/32_1_73.
8
Genetically modified organisms in the United States: implementation, concerns, and public perception.美国的转基因生物:实施情况、问题及公众认知
Adv Biochem Eng Biotechnol. 2007;107:57-68. doi: 10.1007/10_2007_051.
9
US animal biotech regulations "may not be adequate".美国动物生物技术法规“可能不够充分”。
Nat Biotechnol. 2002 Oct;20(10):959. doi: 10.1038/nbt1002-959.
10
Another inconvenient truth. In Europe, no one apparently wants to listen if you have good news about genetically modified organisms (GMOs).另一个难以忽视的真相。在欧洲,如果您有关于转基因生物(GMO)的好消息,显然没人愿意听。
Nat Biotechnol. 2007 Dec;25(12):1330. doi: 10.1038/nbt1207-1330.

引用本文的文献

1
Genetically modified food and consumer risk responsibility: The effect of regulatory design and risk type on cognitive information processing.转基因食品和消费者风险责任:监管设计和风险类型对认知信息处理的影响。
PLoS One. 2021 Jun 9;16(6):e0252580. doi: 10.1371/journal.pone.0252580. eCollection 2021.
2
Experiences in Engaging the Public on Biotechnology Advances and Regulation.公众参与生物技术进展和监管的经验。
Front Bioeng Biotechnol. 2016 Feb 2;4:3. doi: 10.3389/fbioe.2016.00003. eCollection 2016.